title: [Glycemic control and cardiovascular benefit: what do we know today?].
authors.forename: Günther
authors.initials: G
authors.lastname: Egidi
authors.forename: Uwe
authors.initials: U
authors.lastname: Popert
mesh_terms: D000328:Adult; D000367:Age Factors; D015415:Biomarkers; D002318:Cardiovascular Diseases / Q000097:blood* / Q000401:mortality / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D057239:Early Termination of Clinical Trials; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000150:complications / Q000401:mortality; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008875:Middle Aged; D000077205:Pioglitazone; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D000077154:Rosiglitazone; D016019:Survival Analysis; D045162:Thiazolidinediones / Q000627:therapeutic use
chemical_list: D015415:Biomarkers; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D000077205:Pioglitazone; D000077154:Rosiglitazone; D045162:Thiazolidinediones; C517652:hemoglobin A1c protein, human